Cargando…
Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
SIMPLE SUMMARY: Thyroid carcinoma is the most common cancer of the endocrine system and accounts for 12% of all cancer cases in adolescents in the United States. In this paper, we present a double-blind, randomized, placebo-controlled clinical trial aimed at evaluating the effect of probiotics suppl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913142/ https://www.ncbi.nlm.nih.gov/pubmed/36765697 http://dx.doi.org/10.3390/cancers15030740 |
_version_ | 1784885352990769152 |
---|---|
author | Mortazavi, Seyed Mohammad Javad Nowroozi, Saba Haghani, Masoud Zarrini-Monfared, Zinat Gheisari, Farshid Sihver, Lembit |
author_facet | Mortazavi, Seyed Mohammad Javad Nowroozi, Saba Haghani, Masoud Zarrini-Monfared, Zinat Gheisari, Farshid Sihver, Lembit |
author_sort | Mortazavi, Seyed Mohammad Javad |
collection | PubMed |
description | SIMPLE SUMMARY: Thyroid carcinoma is the most common cancer of the endocrine system and accounts for 12% of all cancer cases in adolescents in the United States. In this paper, we present a double-blind, randomized, placebo-controlled clinical trial aimed at evaluating the effect of probiotics supplementation in reducing the acute side-effects of radioiodine therapy in DTC patients. The probiotics’ effectiveness was confirmed for dry mouth and taste loss or change when it was administered prior to the radioiodine treatment. The benefit was not confirmed for other radiation-induced complications such as pain and swelling in the neck, nausea and vomiting, salivary gland swelling, and diarrhea. Further large-scale clinical trials are warranted to improve our knowledge of this quickly evolving field. ABSTRACT: Thyroid carcinoma is the most common cancer of the endocrine system, accounting for 12% of all cancer cases in adolescents in the United States. Radioiodine therapy plays a key role in differentiated thyroid cancer (DTC) treatment. This double-blind, randomized, placebo-controlled clinical trial was aimed at evaluating the effect of probiotics supplementation in reducing the acute side-effects of radioiodine therapy in PTC patients. Fifty-six patients were randomly divided into four groups: one placebo and three intervention groups. The probiotics product used in this study was LactoCare (ZistTakhmir Co., Tehran, Iran), a multi-strain commercially available symbiotic containing 12 strains of probiotic species including Lactobacillus strains, Bifidobacteria strains, and Streptococcus thermophilus, plus Fructo-oligosaccharides as the prebiotic. Group 0 was our placebo group (no probiotics), while the other three groups received probiotics capsules for 2/4 days, starting only 2 days prior to radioiodine therapy, only 4 days after radioiodine therapy or 2 days prior and 4 days after radioiodine therapy. Six patients were withdrawn during the study because of poor compliance or at their own request. The symptoms reported by patients including data about the incidence and duration of each complication were recorded. The probiotics’ effectiveness was confirmed for dry mouth and taste loss or change when it was administered prior to the radioiodine treatment. The benefit was not confirmed for other radiation-induced complications such as pain and swelling in the neck, nausea and vomiting, salivary gland swelling, and diarrhea. Further large-scale clinical trials are warranted to improve our knowledge in this quickly evolving field. |
format | Online Article Text |
id | pubmed-9913142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99131422023-02-11 Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment Mortazavi, Seyed Mohammad Javad Nowroozi, Saba Haghani, Masoud Zarrini-Monfared, Zinat Gheisari, Farshid Sihver, Lembit Cancers (Basel) Article SIMPLE SUMMARY: Thyroid carcinoma is the most common cancer of the endocrine system and accounts for 12% of all cancer cases in adolescents in the United States. In this paper, we present a double-blind, randomized, placebo-controlled clinical trial aimed at evaluating the effect of probiotics supplementation in reducing the acute side-effects of radioiodine therapy in DTC patients. The probiotics’ effectiveness was confirmed for dry mouth and taste loss or change when it was administered prior to the radioiodine treatment. The benefit was not confirmed for other radiation-induced complications such as pain and swelling in the neck, nausea and vomiting, salivary gland swelling, and diarrhea. Further large-scale clinical trials are warranted to improve our knowledge of this quickly evolving field. ABSTRACT: Thyroid carcinoma is the most common cancer of the endocrine system, accounting for 12% of all cancer cases in adolescents in the United States. Radioiodine therapy plays a key role in differentiated thyroid cancer (DTC) treatment. This double-blind, randomized, placebo-controlled clinical trial was aimed at evaluating the effect of probiotics supplementation in reducing the acute side-effects of radioiodine therapy in PTC patients. Fifty-six patients were randomly divided into four groups: one placebo and three intervention groups. The probiotics product used in this study was LactoCare (ZistTakhmir Co., Tehran, Iran), a multi-strain commercially available symbiotic containing 12 strains of probiotic species including Lactobacillus strains, Bifidobacteria strains, and Streptococcus thermophilus, plus Fructo-oligosaccharides as the prebiotic. Group 0 was our placebo group (no probiotics), while the other three groups received probiotics capsules for 2/4 days, starting only 2 days prior to radioiodine therapy, only 4 days after radioiodine therapy or 2 days prior and 4 days after radioiodine therapy. Six patients were withdrawn during the study because of poor compliance or at their own request. The symptoms reported by patients including data about the incidence and duration of each complication were recorded. The probiotics’ effectiveness was confirmed for dry mouth and taste loss or change when it was administered prior to the radioiodine treatment. The benefit was not confirmed for other radiation-induced complications such as pain and swelling in the neck, nausea and vomiting, salivary gland swelling, and diarrhea. Further large-scale clinical trials are warranted to improve our knowledge in this quickly evolving field. MDPI 2023-01-25 /pmc/articles/PMC9913142/ /pubmed/36765697 http://dx.doi.org/10.3390/cancers15030740 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mortazavi, Seyed Mohammad Javad Nowroozi, Saba Haghani, Masoud Zarrini-Monfared, Zinat Gheisari, Farshid Sihver, Lembit Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment |
title | Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment |
title_full | Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment |
title_fullStr | Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment |
title_full_unstemmed | Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment |
title_short | Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment |
title_sort | probiotic bacteria cannot mitigate the adverse effects of radioactive iodine-131 treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913142/ https://www.ncbi.nlm.nih.gov/pubmed/36765697 http://dx.doi.org/10.3390/cancers15030740 |
work_keys_str_mv | AT mortazaviseyedmohammadjavad probioticbacteriacannotmitigatetheadverseeffectsofradioactiveiodine131treatment AT nowroozisaba probioticbacteriacannotmitigatetheadverseeffectsofradioactiveiodine131treatment AT haghanimasoud probioticbacteriacannotmitigatetheadverseeffectsofradioactiveiodine131treatment AT zarrinimonfaredzinat probioticbacteriacannotmitigatetheadverseeffectsofradioactiveiodine131treatment AT gheisarifarshid probioticbacteriacannotmitigatetheadverseeffectsofradioactiveiodine131treatment AT sihverlembit probioticbacteriacannotmitigatetheadverseeffectsofradioactiveiodine131treatment |